论著
目的 探讨基于中药熏蒸配合穴位按摩的健康管理对稳定期肺肾气虚型慢阻肺的疗效。方法 选取2020年1月—2021年1月在我院接受治疗的稳定期肺肾气虚型慢阻肺患者120例为研究对象,随机分为对照组和干预组。对照组采用西医常规干预,干预组在此基础上实施为期1年的中药熏蒸配合穴位按摩的健康管理,比较干预前后2组患者肺功能、血氧指标以及生活质量的差异。结果 干预前,2组患者第1秒用力肺活量(FEV1)、第1秒用力肺活量占预计值百分比(FEV1%)、用力肺活量(FVC)、第1秒用力肺活量占用力肺活量的比值(FEV1/FVC%)等指标比较差异无统计学意义(P>0.05),干预后,2组患者的FEV1、FEV1%、FVC、FEV1/FVC%明显上升,且干预组患者优于对照组(P<0.05);实施相关干预前,干预组和对照组患者的血氧指标比较差异无统计学意义(P>0.05),干预后,2组患者的PaO2、和SpO2上升,PaCO2下降,且干预组的变化幅度大于对照组(P<0.05);干预前2组患者在圣乔治问卷(SGRQ)生活质量评分比较差异无统计学意义(P>0.05),干预后2组患者的SGRQ生活质量评分降低,且干预组患者的SGRQ生活质量指标评分更低(P<0.05)。结论 中药熏蒸配合穴位按摩应用于稳定期肺肾气虚型慢阻肺患者中,能够提高患者的肺功能,改善血氧指标,提高患者的生活质量。
Objective To explore the effect of health management based on traditional Chinese medicine fumigation combined with acupoint massage on stable chronic obstructive pulmonary disease(COPD)with lung-kidney deficiency.Methods A total of 120 patients with stable COPD and lung-kidney deficiency who received treatment in our hospital from January 2020 to January 2021 were selected as the study objects and randomly divided into control group and intervention group.The control group received conventional Western medicine intervention,and the intervention group received 1-year traditional Chinese medicine fumigation combined with acupoint massage on the basis of Western management.The differences of lung function,blood oxygen index and quality of life between the two groups were compared before and after intervention.Results Before intervention,there were no significant differences in forced expiratory volume in one second(FEV1),the first second forced vital capacity percentage of expected value(FEV1%),forced vital capacity(FVC),the ratio of the first second forced vital capacity of forced vital capacity(FEV1/FVC%)between the two groups(P>0.05),but after intervention,the FEV1,FEV1%,FVC,FEV1/FVC% of the two groups increased significantly,and those in the intervention group were better(P<0.05).Before the implementation of relevant intervention,there was no difference in blood oxygen index between the two groups(P>0.05).After the intervention,PaO2 and SpO2 of the two groups were significantly increased,while PaCO2 was significantly decreased,and the change in the intervention group was significantly greater(P<0.05).Before intervention,there were no significant differences in the quality of life scores of St George’s Respiratory Questionnaire(SGRQ)between the two groups(P>0.05).After intervention,the scores of SGRQ of the two groups were significantly decreased,and the scores of the intervention group were significantly lower(P<0.05).Conclusions Traditional Chinese medicine fumigation combined with acupoint massage can significantly improve lung function,blood oxygen index and life quality of stable COPD patients with lung-kidney deficiency.
论著
目的 探讨便携式内窥镜视频系统辅助鼻咽喉检查治疗效果。方法 2019年1月1日—2019年12月31日,选取本院眼耳鼻颌面外科院内住院查房、门急诊中实施的168例患者作为研究对象,采用随机法对纳入患者进行分组,各分为84例。实验组采用自主研制的便携式内窥镜视频系统,对照组采用传统的喉镜腔镜系统。比较两组患者检查治疗效果、医务人员使用过程中的满意度和患者检查治疗过程中的满意度并进行效果评价。结果 两组患者鼻咽喉镜腔镜系统检查治疗时间比较,实验组时间为13.4 min;对照组时间为22.9 min;患者对鼻咽喉镜腔镜系统检查治疗的满意度比较主要从检查治疗效果、检查治疗体验效果进行评价,实验组满意度91.67%,对照组满意度86.91%,两组比较差异有统计学意义(χ2=4.695,P=0.030);医务人员对两组鼻咽喉镜腔镜系统检查治疗使用的满意度评价主要从性能参数、检查治疗使用效果等方面进行评价,性能参数主要包括便携性、图像质量、操作方法、运营成本等方面,实验组满意度92%,对照组满意度77%,两组比较差异有统计学意义(χ2=6.834,P=0.009)。结论 便携式内窥镜视频系统操作简单、使用方便,不仅能够满足患者的诊疗需要并减少患者的诊疗时间,而且能够满足医务人员使用过程中的便携性,能够提高医疗质量,非常适合临床使用。
Objective To investigate the therapeutic effect of portable endoscopic video system assisted nasopharynx examination. Methods From January 1, 2019 to December 31, 2019, 168 patients in the department of ophthalmology, otorhino-maxillofacial surgery in our hospital were selected as the research objects. The patients were randomly divided into 84 cases. The experimental group used the self-developed portable endoscope video system, while the control group used the traditional laryngoscope system. The treatment effect, satisfaction of medical staff and satisfaction of patients in the process of examination and treatment were compared between the two groups, and the effect was evaluated. Results Compared to the treatment time of nasopharynx and laryngoscope system between the two groups, the experimental group time was 13.4 min; the control group time was 22.9 min; the patients' satisfaction with nasopharyngoscope system examination and treatment was mainly evaluated from the examination and treatment effect, the experimental group satisfaction was 91.67%, while the control group was 86.91%, the difference was statistically significant (χ2=4.695, P=0.030); medical staffs' satisfaction evaluation on the use of nasopharynx and laryngoscope system in the two groups was mainly evaluated from the performance parameters, examination and treatment effect, and the performance parameters mainly included portability, image quality, operation methods, operating costs and other aspects. The satisfaction of the experimental group was 92%, and that of the control group was 77%. The difference between the two groups was statistically significant (χ2=6.834, P=0.009). Conclusion The portable endoscopic video system is easy to operate use. It can not only meet the needs of patients and reduce the diagnosis and treatment time of patients, but also meet the portability of medical staffs in the process of using, and can improve the quality of medical treatment, which is very suitable for clinical use.
论著
目的 探讨体外受精治疗中第3天(D3)不同质量卵裂期胚胎培养至囊胚的发育潜能,为囊胚培养提供实验室依据。方法 对2015年4月—2019年4月D3移植或冷冻后剩余行囊胚培养的5 510枚胚胎进行了回顾性分析。按D3胚胎质量、卵裂球数目、均一性及碎片率分组,比较囊胚形成率,优质囊胚形成率及可利用囊胚形成率,并分析各因素与可利用囊胚形成的相关性。结果 D3优质胚胎的囊胚形成率,优质囊胚形成率及可利用囊胚形成率与非优质胚胎组相比有统计学差异(P<0.05);4-6细胞组及<4细胞组与7-9细胞组相比有统计学差异(P<0.05),但融合期胚胎(CP)组及> 9细胞组与7-9细胞组相比差异无统计学意义;卵裂球大小差异(+)组和(++/+++)组与卵裂球大小均匀(-)相比有统计学差异(P<0.05); 10%~25%组及碎片>25%组与碎片≤10%组相比有统计学差异(P<0.05)。 Logistic分析结果表明,D3胚胎质量、卵裂球数目、均一性及胚胎碎片率与可利用囊胚形成显著相关(P<0.05)。 结论 D3胚胎质量、卵裂球数目、均一性及胚胎碎片均会影响到囊胚的形成及质量,其中胚胎质量和卵裂球数目对可利用囊胚形成的影响较大。
Objective To explore the developmental potential of day 3(D3) different quality embryos cultured to blastocyst in vitro fertilization treatment, and to provide laboratory basis for blastocyst culture. Methods A total of 5 510 embryos with blastocyst culture remained after D3 transplantation or freezing from April 2015 to April 2019 were analyzed retrospectively. They were divided into groups according to embryo quality, blastomere number, blastomere homogeneity and fragment rate in D3. And the blastocyst formation rate, high quality blastocyst formation rate and available blastocyst formation rate were compared between the groups.The correlation within each factor and available blastocyst formation was analyzed. Results The blastocyst formation rate, high quality blastocyst formation rate and available blastocyst formation rate of D3 high quality embryo group were higher than those of non-high quality embryo group (P<0.05); compared with 7- 9 cell group, 4- 6 cell group and<4 cell group were lower (P<0.05), but there was no significant difference in CP group or >9 cell group. Compared with the normal size of the blastomere (-), the difference in the size of the blastomere (+) group and the (++/+++) group decreased (P<0.05); compared with the fragment ≤ 10%, the difference in the size of the blastomere between the 10%~25% group and the fragment>25% group decreased (P<0.05). The results of logistic analysis suggested that the embryo quality, blastomere number, homogeneity and fragment rate of D3 were correlated with available blastocyst formation (P<0.05). Conclusion D3 embryo quality, blastomere number, homogeneity and embryo fragment may affect the formation and quality of blastocyst, especially the embryo quality and blastomere number.
论著
目的 探讨35周岁以下患者行D5单囊胚移植的可行性。方法 回顾性分析2016年1月—2019年7月期间,女方年龄≤35岁,在本中心行新鲜周期全胚冻后第一冻融移植的663个周期,根据胚胎发育天数及囊胚移植数目分为三组:D3双优胚移植组(D3双优组:n=508)、D5单囊胚移植组(D5单囊组:n=47)、D5双囊胚移植组(D5双囊组:n=108),对三组的临床结局进行比较分析。结果 D5双囊组临床妊娠率高于D3双优组及D5单囊组,且差异有统计学意义(P<0.05),但D5单囊组与D3双优组相比,无统计学差异(P>0.05);D5单囊胚的多胎率低于D5双囊组及D3双优组,差异均有统计学意义(P<0.001),D3双优组的多胎率也低于D5双囊组,差异亦有统计学意义(P<0.05);D5单囊组和D5双囊组的种植率都高于D3双优组,差异都有统计学意义(分别是P<0.05,P<0.001),而D5单囊组合D5双囊组之间无统计学差异(P>0.05);但三组之间的早期流产率及宫外孕率均无统计学差异(P>0.05)。结论 年龄≤35周岁的患者全胚冷冻后第一冻融移植周期选择D5单囊胚进行移植,既能获得良好的临床妊娠率和种植率,又极大降低多胎妊娠率。
Objective To investigate the clinical outcomes of the single blastocyst transfer of day 5 in the women under 35 years old. Methods A retrospective study was conducted to analyze clinical outcomes of women less than 35 years old and experienced embryo transfer in the first frozen-thawed cycles from January 2016 to July 2019 in the Center of Reproductive Medicine of Guangzhou Women and Children's Medical Center. According to the embryo developmental days and transfer blastocyst numbers, all patients were divided into three groups: double high-quality cleavage embryo transfer of day 3 (n=508), single blastocyst transfer of day 5(n=47), double blastocyst transfer of day 5(n=108). The clinical outcomes were compared. Results The clinical pregnancy rate of the double blastocyst transfer of day 5 was higher than the other two groups,and the differences were statistically significant(P<0.05). However, there was no statistical difference between the single blastocyst transfer of day 5 and the double high-quality cleavage embryo transfer of day 3(P>0.05). The multiple pregnancy rate of the single blastocyst transfer of day 5 was lower than the other two groups, and the differences were statistically significant (P<0.001),and that of the double high-quality cleavage embryo transfer of day 3 was even lower than that of the double blastocyst transfer of day 5,and the difference was statistically significant(P<0.05). The implanting rate of the double high-quality cleavage embryo transfer of day 3 was lower than the other two groups, and the differences were statistically significant (P<0.05;P<0.001),but there was no statistical difference between the single blastocyst transfer of day 5 and the double blastocyst transfer of day 5 (P>0.05). However, the early miscarriage rate and the ectopic pregnancy rate did not exhibit statistical differences (P>0.05). Conclusion Single blastocyst transfer of day 5 can ensure clinical pregnancy rate and implantation rate while effectively reducing multiple pregnancy in the women undergoing the first frozen-thawed cycles of under 35 years old.